Impact of HAART on liver histology of HIV/HCV coinfected patients.

De Bona, A; Sitia, G; Uberti-Foppa, C; Galli, L; Ciuffreda, D; Gallotta, G; Paties, C; Lazzarin, A

De Bona, A; Sitia, G; Uberti-Foppa, C; Galli, L; Ciuffreda, D; Gallotta, G; Paties, C; Lazzarin, A.

Affiliation

De Bona A; Infectious Diseases Department, San Raffaele Scientific Institute IRCCS, Milan, Italy.

J Biol Regul Homeost Agents ; 17(2): 195-7, 2003.

Article in En | MEDLINE | ID: mdl-14518723

Subject(s)

Antiretroviral Therapy, Highly Active/adverse effects; HIV Infections/complications; Hepatitis C/pathology; Liver/pathology; Adult; Alanine Transaminase/blood; Biopsy; CD4 Lymphocyte Count; Drug Therapy, Combination; Fibrosis; Hepatitis C/complications; Hepatitis C/drug therapy; Humans; Inflammation/pathology; Liver/drug effects; Protease Inhibitors/therapeutic use; RNA, Viral/blood; RNA, Viral/genetics

Search on Google

XML

PubMed Links

Database: MEDLINE Main subject: HIV Infections / Hepatitis C / Antiretroviral Therapy, Highly Active / Liver Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Humans Language: En Year: 2003 Type: Article

Search on Google

XML

PubMed Links